How much do you know about OncoDNA?

Create an informative and engaging illustration showing the innovations in cancer therapy and biomarker testing, featuring elements such as DNA strands, laboratory equipment, and visuals representing cancer research.

Test Your Knowledge on OncoDNA

Are you ready to learn more about OncoDNA and its innovative approaches to cancer theranostics? This quiz challenges your knowledge and helps you discover fascinating facts about the company and its contributions to cancer treatment.

Join us and see how much you know!

12 engaging questions
Learn about biomarker testing and liquid biopsy
Discover OncoDNA's unique mission and achievements

12 Questions3 MinutesCreated by ExploringDNA101

Over the years, OncoDNA has developed a series of biomarker tests. What is biomarker testing?

Biomarker testing is a way to understand the molecular particularities of a tumor and identify the most effective treatment for a patient, or monitor disease progression.

Biomarker testing is a radiology test used to find out how far a cancer has spread and whether a treatment is working.

Biomarker testing is a series of symptoms that may indicate the development of a cancer.

OncoDEEP is OncoDNA’s flagship biomarker test. It is a comprehensive solution that screens for all the cancer markers (DNA, RNA and protein) present in a tumor tissue. Why does it matter?

Screening for all biomarkers in one single test helps identify relevant immunotherapy options.

Screening for all biomarkers in one single test helps identify clinical trial options.

Screening for all biomarkers in one single test increases the likelihood to identify all relevant cancer treatments (chemotherapy, immunotherapy, targeted therapy and hormone therapy; and potential clinical trial options) in a fast turnaround time.

Which company did OncoDNA acquire in 2017 as part of an effort to expand its presence in Europe and Latin America?

BioSequence

Oncovision

Oncogenomics

OncoDNA is also specializing in liquid biopsy testing. What is the potential of this promising technology?

Liquid biopsy is a fast and minimally invasive method to understand the reasons why a cancer developped.

Liquid biopsy is a fast and minimally invasive method to identify relevant treatment options and monitor disease progression in real time.

Liquid biopsy is a cost-effective method to predict the development of genetic diseases.

What is OncoDNA's mission?

To empower physicians, biopharma companies and researchers to create a world without cancer

To empower physicians, biopharma companies and researchers to make the best use of artificial intelligence

To empower physicians, biopharma companies and researchers to deliver the promise of precision medicine to patients living with cancer and genetic disease

Is OncoDNA present in the US?

No, it is not.

Yes, OncoDNA collaborates with a subcontracted lab in the US.

Yes, OncoDNA collaborates with a subcontracted lab and has an entity in the US.

Why did OncoDNA acquire IntegraGen in 2020?

To acquire its first accredited laboratory.

To access the French market and specialize in rare diseases.

To diversify its portfolio with genomic services and interpretation software for research use.

What makes OncoDNA unique?

Its location at the heart of Europe, its exponantial growth, its business model

Its flexible solution portfolio, its end-to-end customer support, and its dynamic proprietary database

Its price advantage, its distribution network, its entrepreneurial mindset

How much do you know about OncoDNA?

Test Your Knowledge on OncoDNA

More Quizzes